In Uganda, where malaria transmission is a year-round threat and health challenges are compounded by health worker shortages and inequities, Malaria Consortium partners with the Ministry of Health and local stakeholders to strengthen community-based health systems.
We focus on integrated case management, disease surveillance and innovative communication methods to facilitate behaviour change. This supports improved health outcomes for those most susceptible to malaria and other diseases — especially women, children and newborns.
Our work includes distributing long-lasting insecticidal nets and insect-repellent systems, supporting vaccine and seasonal malaria chemoprevention studies, and responding to emerging health threats. We also monitor drug resistance and how seasonal malaria chemoprevention impacts on children’s immune responses to the disease.
As well as Malaria, we are addressing the growing risks from other mosquito-borne diseases, or arboviruses, strengthening Uganda’s capacity to detect and respond to these threats. Plus, we’re developing climate and disease modelling to anticipate and prepare for future outbreaks driven by climate change.
By training health workers, advancing digital health solutions and addressing gender barriers, we are ensuring better access to prevention, diagnosis and treatment for malaria and other diseases for all.
Uganda at a glance
▶ Approximately 95 percent of the country has stable malaria transmission.
▶ Uganda is the third highest contributor of global malaria cases and the eighth highest contributor of malaria deaths.
▶ Malaria is responsible for 50 percent of outpatient department diagnoses, 15−20 percent of hospital admissions and 20 percent of in-patient deaths.
Our impact
▶ Malaria Consortium has been working in Uganda since 2003, with an office in Kampala.
▶ We have helped reduce maternal mortality rates by 44 percent, and under-five mortality rates by 18.5 percent, as of 2022.
▶ We have trained over 40,000 village health teams to diagnose and treat pneumonia, malaria and diarrhoea in children under five since 2015.
▶ In 2025, Malaria Consortium is supporting the introduction and rollout of the malaria vaccine as part of Uganda’s Essential Programme on Immunisation, playing a leading role in community engagement and health system preparedness to ensure high uptake and acceptance.
Anthony Nuwa
Senior Country Technical Coordinator, Uganda
As we forge ahead in our battle against malaria, our focus remains steadfast on implementing scientifically backed strategies that promise real results. Our commitment at Malaria Consortium is to not only fight malaria but to lead by example, pioneering innovative practices in community health management and prevention that can be replicated and scaled across regions most in need.
